Chambers, RC;
(2022)
Preferential PDE4B Inhibition - A Step toward a New Treatment for Idiopathic Pulmonary Fibrosis.
New England Journal of Medicine
, 386
(23)
pp. 2235-2236.
10.1056/NEJMe2205411.
Preview |
Text
nejme2205411.pdf - Published Version Download (306kB) | Preview |
| Type: | Article |
|---|---|
| Title: | Preferential PDE4B Inhibition - A Step toward a New Treatment for Idiopathic Pulmonary Fibrosis |
| Location: | United States |
| Open access status: | An open access version is available from UCL Discovery |
| DOI: | 10.1056/NEJMe2205411 |
| Publisher version: | https://doi.org/10.1056/NEJMe2205411 |
| Language: | English |
| Additional information: | This version is the version of record. For information on re-use, please refer to the publisher’s terms and conditions. |
| Keywords: | Cyclic Nucleotide Phosphodiesterases, Type 4, Humans, Idiopathic Pulmonary Fibrosis, Phosphodiesterase 4 Inhibitors |
| UCL classification: | UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Div of Medicine > Respiratory Medicine UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences UCL UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Div of Medicine |
| URI: | https://discovery.ucl.ac.uk/id/eprint/10153028 |
Downloads since deposit
Loading...Download activity - last month
Loading...Download activity - last 12 months
Loading...Downloads by country - last 12 months
Loading...Archive Staff Only
 |
View Item |
